Scholars Central

Conference abstractPublished 23 Jul 2018

Clinical application of 192Ir HDR interstitial brachytherapy and 125I seeds LDR permanent implantation for recurrence of GYN after pelvic EBRT

Authors: Ping Jiang

Peking University Third Hospital, China

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Purpose: To evaluate the feasibility of 192Ir HDR interstitial brachytherapy and125I LDR permanent implantation brachytherapy for recurrence of GYN aft er pelvic external beam irradiation. Materials & Methods: Pelvic recurrence of GYN includes central recurrence and pelvic sidewall recurrence, diff erent site of relapse associate diff erent management in our center. In our study, all recurrence patients aft er pelvic adjuvant external beam radiotherapy (EBRT) or radical chemoradiotherapy. 11 patients in our center diagnosed with central recurrence of GYN they received 192Ir HDR interstitial brachytherapy under CT guidance with 3D-printing template assisted. Among them, 5 cases under local anesthesia with vaginal insertion template and 6 cases under epidural anesthesia with combined vaginal and perineal insertion template. GTV prescription dose was 5-6 Gy/f, 2-6 f, 1-2 f/W. Totally 45 fraction treatment of 11patients. 21 patients with pelvic sidewall recurrence received 125I seeds implantation under the CT guidance with 3D-PNCT assistant. Prescription D90 of GTV was 120-150 Gy, Th e local control probabilities were calculated and complications and early toxicities were analyzed by the Kaplan-Meier method (SPSS 16.0). Results: 11 patients with central recurrence, totally 229 needles were inserted for 45 FDR applications, median 6 (3-9) needles per fraction, mean inserting depth was 8.3±3.4 cm (2-13.7 cm), mean CT scan 3 (1-5) times, during CT guidance procedure. Actual dosimetry parameters of median V100 were 83±4.5%. Early side eff ects of grade I/II urethritis were found in 45% patients and relieved aft er symptomatic treatment. Totally response rate (1 month later) was 91%, 1 lesions had complete remission CR (9%) and 9 had partial remission PR (82%). Among 21 patients with sidewall recurrence, 669 (median 47, 25- 113) seeds implanted, total 132 needles (median 9, 6-21) were implanted actually. Th e activity of 125 I seeds ranged from 0.3 mCi to 0.8 mCi (median: 0.69 mCi). Th e total number of seeds implanted ranged from 3 to 89 (median: 20). Actual dosimetry parameters of median V100 were 93±4.5%. Totally response rate (1 month later) was 85%, 3 lesions had complete remission CR (14%) and 15 had partial remission PR (71%). severe complications were not seen. Conclusion: 192Ir HDR interstitial brachytherapy for central recurrence and 125I LDR permanent implantation for pelvic sidewall recurrence of GYN under CT guidance have good dosimetry parameters. It is clinically feasible and high effi ciency with low complications. However long-term clinical outcomes should be further investigated.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Ping Jiang”